In order to evaluate the safety of the novel PD-L1_1 and ID-1 mAbs, we investigated their effects on human fetal cardiomyocytes (HFCs) co-cultured in presence of hPBMCs, and compared their anti-tumor effects with eventual cardiac side effects. The gene discussed is ID1; the disease is neoplasm.